Table 1. Clinical profiles of patients... | American Society of Hematology

Table 1.

Clinical profiles of patients with PNH

						Granulocytes
Patient no.	Sex/age, y	Diagnosis	Duration, y^*	Hemoglobin, g/L	Platelets, × 10⁹/L	Cell no., × 10⁹/L	DAF^–/CD59^–, %†
1	M/24	PNH	2	88	75	1.7	79
2	M/29	PNH	12	62	232	1.3	94
3	M/35	PNH	15	59	270	0.2	90
4	F/56	PNH	12	92	193	2.2	84
5	M/66	PNH	9	133	191	3.6	44
6‡	F/71	PNH	24	101	67	1.4	100
7	M/79	PNH	7	102	124	1.9	35
8	F/79	PNH	7	90	194	1.8	72
9	F/24	AA-PNH	8	69	216	2.0	90
10	F/27	AA-PNH	8	127	76	1.5	15
11	F/39	AA-PNH	1	103	96	1.4	1
12	M/64	AA-PNH	9	116	121	1.5	1
13	F/73	AA-PNH	8	87	37	2.1	95
14	M/81	AA-PNH	10	117	69	2.6	1

						Granulocytes
Patient no.	Sex/age, y	Diagnosis	Duration, y^*	Hemoglobin, g/L	Platelets, × 10⁹/L	Cell no., × 10⁹/L	DAF^–/CD59^–, %†
1	M/24	PNH	2	88	75	1.7	79
2	M/29	PNH	12	62	232	1.3	94
3	M/35	PNH	15	59	270	0.2	90
4	F/56	PNH	12	92	193	2.2	84
5	M/66	PNH	9	133	191	3.6	44
6‡	F/71	PNH	24	101	67	1.4	100
7	M/79	PNH	7	102	124	1.9	35
8	F/79	PNH	7	90	194	1.8	72
9	F/24	AA-PNH	8	69	216	2.0	90
10	F/27	AA-PNH	8	127	76	1.5	15
11	F/39	AA-PNH	1	103	96	1.4	1
12	M/64	AA-PNH	9	116	121	1.5	1
13	F/73	AA-PNH	8	87	37	2.1	95
14	M/81	AA-PNH	10	117	69	2.6	1

AA-PNH indicates aplastic anemia–PNH syndrome.

Years after diagnosis

DAF^–/CD59^– indicates granulocytes negative for both DAF and CD59

Patient no. 6 was a PNH patient with coexisting congenital deficiency of complement C9⁵⁰